Home>Topics>Authors>Lauren Migliore

Lauren Migliore

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
  1. Buy One, Get One Free At Charles River Laboratories

    Headlines

    Sun, 13 May 2012

    By Morningstar : By Lauren Migliore Contract research organizations dramatically cut costs and development time for drugmakers. As cutbacks continue in response to

  2. Top Biotech Acquisition Candidates

    Video Reports

    Thu, 5 Apr 2012

    M&A environment is biotech analyst Lauren Migliore . Thanks for joining me, Lauren. Lauren Migliore : Good to be here, Karen. Andersen ..... acquirer. Andersen : OK, great. Thanks, Lauren . Migliore : Thanks, Karen. Andersen : So for

    Lauren Migliore found at 0:15, 3:20

    Morningstar. With me today to discuss the M&A environment is biotech analyst Lauren Migliore . Thanks for joining me, Lauren. Lauren Migliore : Good to be here, Karen. Andersen : So, just to recap 2011, it was a relatively light year for biotech M&A.
    whether they are targeted by an acquirer. Andersen : OK, great. Thanks, Lauren . Migliore : Thanks, Karen. Andersen : So for our full biotech takeout list for 2012, as well as our M&A outlook for other
  3. Savient Loses CEO to Dendreon Amid Management Shakeup

    Commentary

    Wed, 1 Feb 2012

    ImClone to Eli Lilly LLY in 2008, and we think his appointment could reinvigorate takeover speculation for Dendreon. The firm ranked No. 4 on Morningstar's Biotech Takeover List last year. Lauren Migliore also contributed to this note.

  4. Contract Research Organizations Still On Sale As Industry Rebounds

    Headlines

    Thu, 12 Jan 2012

    By Morningstar : By Lauren Migliore We think the contract research organization (CRO) industry is on the rebound, as evidenced by a resurgence in new business activity

  5. Gen-Probe: New Tests Key to Increasing Revenue

    Video Reports

    Thu, 10 Nov 2011

    Lauren Migliore : My name is Lauren Migliore ; I am a health-care analyst here at Morningstar. Gen ..... re very welcome. Thanks for having me. Migliore : I'm Lauren Migliore for Morningstar. Thanks for joining us.

    Lauren Migliore found at 0:00, 8:30

    Lauren Migliore : My name is Lauren Migliore ; I am a health-care analyst here at Morningstar. Gen-Probe is a leading provider of molecular diagnostic products used to diagnose human diseases
    Watts : You're very welcome. Thanks for having me. Migliore : I'm Lauren Migliore for Morningstar. Thanks for joining us.
  6. A CRO Under the Microscope

    Video Reports

    Thu, 10 Nov 2011

    Lauren Migliore : Hi, my name is Lauren Migliore . I'm a health-care analyst here at Morningstar. Contract ..... Thanks for joining us, Jim. James F. Winschel : Thanks, Lauren . Migliore : Well, let's start off with an overview of the industry

    Lauren Migliore found at 0:00, 9:14

    Lauren Migliore : Hi, my name is Lauren Migliore . I'm a health-care analyst here at Morningstar. Contract research organization Parexel is a leading provider of outsourced research and development services to pharmaceutical and biotechnology companies. With us today is the firm's CFO, Jim Winschel, to speak with us about the competitive landscape in the drug development industry. Thanks for joining us, Jim. James F. Winschel : Thanks, Lauren . Migliore : Well, let's start off with an overview of the industry. Can you outline the benefits that CROs offer over traditional in-house
    your thoughts. Winschel : Okay. Thanks, Lauren. Appreciate it. Migliore : I'm Lauren Migliore for Morningstar. Thanks for joining us.
  7. Option Spotlight: Keep Your Portfolio Healthy With These Health-Care Picks

    Headlines

    Sat, 5 Nov 2011

    contract research organizations) like Icon are absolutely essential to his business. Here is what Morningstar analyst Lauren Migliore has to say about the firm: "Icon's client-focused operating model and growing scale have helped it gain entrance

  8. Why You Shouldn't Bail On Biotech

    Headlines

    Wed, 2 Nov 2011

    By Morningstar : By Lauren Migliore The biotechnology sector has been hit especially hard as investors flee high-risk assets amid recent market uncertainty. Compounding

  9. Personalized Medicine is the Future

    Video Reports

    Fri, 2 Sep 2011

    Lauren Migliore : Hi, my name is Lauren Migliore . I'm a health-care analyst here at Morningstar. Gen ..... comments and for being with us today. Rosenman : Thank you, Lauren . Migliore : I'm Lauren Migliore for Morningstar. Thanks for joining

    Lauren Migliore found at 0:05, 9:49

    Lauren Migliore : Hi, my name is Lauren Migliore . I'm a health-care analyst here at Morningstar. Gen-Probe is a leading provider of molecular diagnostic products used to diagnose human diseases and
    your comments and for being with us today. Rosenman : Thank you, Lauren . Migliore : I'm Lauren Migliore for Morningstar. Thanks for joining us.  
  10. Going Global to Ease Drug Trial Process

    Video Reports

    Fri, 2 Sep 2011

    Lauren Migliore : Contract research organization, Parexel is a leading provider of ..... for being here today. Winschel : Okay. Thank you. Migliore : I'm Lauren Migliore for Morningstar. Thanks for joining us.

    Lauren Migliore found at 0:05, 10:27

    Lauren Migliore : Contract research organization, Parexel is a leading provider of outsourced research and development services to pharmaceutical and biotechnology companies. We're pleased
    for being here today. Winschel : Okay. Thank you. Migliore : I'm Lauren Migliore for Morningstar. Thanks for joining us.  
« Prev12Next »
Content Partners